Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1
1(100.0%)
1Total
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06221397Completed

AI-based Medical Device Validation for Early Melanoma Detection

Role: collaborator

NCT06228014Completed

Pilot Study: AI Algorithm for Dermatology Referral Optimization

Role: collaborator

NCT03311178Phase 1Terminated

Dobutamine in the Treatment of Haemodynamic Insufficiency in the Immediate Postnatal Period

Role: collaborator

All 3 trials loaded